SciBase Holding AB (OSTO:SCIB) Piotroski F-Score: 3 (As of Jul. 04, 2026) — 25% Below Median


OSTO:SCIB SciBase Holding AB OSTO:SCIB
50 GF Score
Price kr33.80
GF Value kr21.74
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SciBase Holding AB Piotroski F-Score?

SciBase Holding AB OSTO:SCIB +0.30% 50 Piotroski F-Score is 3 as of Jul. 04, 2026, which is 25% below its 10-year median of 4.00. GuruFocus rates OSTO:SCIB with a GF Score™ of 50/100 and a GF Value™ of kr21.74 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, SciBase Holding AB ranks worse than 76.67% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SciBase Holding AB has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for SciBase Holding AB's Piotroski F-Score or its related term are showing as below:

OSTO:SCIB' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 3

During the past 13 years, the highest Piotroski F-Score of SciBase Holding AB was 6. The lowest was 2. And the median was 4.

SciBase Holding AB  (OSTO:SCIB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


SciBase Holding AB Piotroski F-Score Related Terms


SciBase Holding AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for SciBase Holding AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciBase Holding AB Piotroski F-Score Chart

SciBase Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 3.00 5.00 4.00 2.00

SciBase Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 3.00 2.00 3.00

OSTO:SCIB vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, SciBase Holding AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Piotroski F-Score falls into.


OSTO:SCIB
50GF Score
SciBase Holding AB OSTO:SCIB
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -26.589 + -18.832 + -25.3 + -24.49 = kr-95.21 Mil.
Cash Flow from Operations was -20.466 + -17.287 + -20.824 + -26.573 = kr-85.15 Mil.
Revenue was 8.791 + 10.339 + 12.475 + 14.278 = kr45.88 Mil.
Gross Profit was 5.821 + 6.207 + 7.854 + 7.025 = kr26.91 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(60.052 + 52.853 + 53.985 + 52.169 + 103.694) / 5 = kr64.5506 Mil.
Total Assets at the begining of this year (Mar25) was kr60.05 Mil.
Long-Term Debt & Capital Lease Obligation was kr21.79 Mil.
Total Current Assets was kr98.65 Mil.
Total Current Liabilities was kr23.79 Mil.
Net Income was -15.05 + -17.753 + -21.677 + -20.682 = kr-75.16 Mil.

Revenue was 6.641 + 8.408 + 8.598 + 8.856 = kr32.50 Mil.
Gross Profit was 4.592 + 6.364 + 5.889 + 6.242 = kr23.09 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(50.583 + 73.706 + 56.079 + 61.731 + 60.052) / 5 = kr60.4302 Mil.
Total Assets at the begining of last year (Mar24) was kr50.58 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr55.19 Mil.
Total Current Liabilities was kr16.03 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SciBase Holding AB's current Net Income (TTM) was -95.21. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SciBase Holding AB's current Cash Flow from Operations (TTM) was -85.15. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-95.211/60.052
=-1.58547592

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-75.162/50.583
=-1.48591424

SciBase Holding AB's return on assets of this year was -1.58547592. SciBase Holding AB's return on assets of last year was -1.48591424. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

SciBase Holding AB's current Net Income (TTM) was -95.21. SciBase Holding AB's current Cash Flow from Operations (TTM) was -85.15. ==> -85.15 > -95.21 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=21.789/64.5506
=0.33754915

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/60.4302
=0

SciBase Holding AB's gearing of this year was 0.33754915. SciBase Holding AB's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=98.65/23.792
=4.14635171

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=55.194/16.025
=3.44424337

SciBase Holding AB's current ratio of this year was 4.14635171. SciBase Holding AB's current ratio of last year was 3.44424337. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

SciBase Holding AB's number of shares in issue this year was 8.197. SciBase Holding AB's number of shares in issue last year was 2.987. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=26.907/45.883
=0.58642635

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=23.087/32.503
=0.71030366

SciBase Holding AB's gross margin of this year was 0.58642635. SciBase Holding AB's gross margin of last year was 0.71030366. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=45.883/60.052
=0.76405449

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=32.503/50.583
=0.64256766

SciBase Holding AB's asset turnover of this year was 0.76405449. SciBase Holding AB's asset turnover of last year was 0.64256766. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+1+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SciBase Holding AB has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
SciBase Holding AB (OSTO:SCIB) has a Piotroski F-Score of 3 as of Jul. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on SciBase Holding AB and its competitors. This is 25% below median its historical median of 4.00. Over the past decade, SciBase Holding AB's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, SciBase Holding AB ranks #618 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 76.7%.
Is SciBase Holding AB's Piotroski F-Score too high?
SciBase Holding AB's current Piotroski F-Score of 3 is 25% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. SciBase Holding AB's value of 3 is 40% below this industry median. Based on the distribution chart, SciBase Holding AB ranks #618 out of 806 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SciBase Holding AB has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SciBase Holding AB ranks #618 out of 806 companies for Piotroski F-Score. This places SciBase Holding AB in the lower half of its industry. The industry median Piotroski F-Score is 5.00. SciBase Holding AB's value of 3 is 40% below this benchmark. Historically, SciBase Holding AB's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, SciBase Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SciBase Holding AB's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on SciBase Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SciBase Holding AB's current Piotroski F-Score is 3, which is 25% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr21.74, compared to a current price of kr33.80 — trading 55.5% above its estimated fair value. The current Piotroski F-Score is 3, which is 25% below median its 10-year median of 4.00 and 40% below the Medical Devices & Instruments industry median of 5.00. SciBase Holding AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current Piotroski F-Score is 3 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?

Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued. The current stock price of kr33.80 is trading 55.5% above its estimated GF Value™ of kr21.74. GuruFocus considers SciBase Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:SCIB:

  • Piotroski F-Score: 3 (25% below median its 10-year median of 4.00)
  • GF Value™: kr21.74 vs. price of kr33.80 (55.5% above fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 40% below the Medical Devices & Instruments median (#618 of 806)

No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SciBase Holding AB Business Description

Address Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
50GF Score

Get the complete analysis for OSTO:SCIB

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr33.80
Price
kr21.74
GF Value